University of Missouri-Columbia
Columbia, Missouri, 65212, United States
NCT Number: NCT03068091
The purpose of this study is to determine whether patient with ILD have altered lung compliance on chest CT before they have macroscopic structural changes on CT.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Columbia, Missouri, 65212, United States
Interstitial lung disease (ILD) is a group of lung disorders in which the lung tissues become inflamed and then damaged. Idiopathic Pulmonary Fibrosis (IPF) is one of the subtypes of ILD which has characteristic histological and CT features. It is well known that microscopic fibrosis occurs in the lungs of IPF patients well before the structural changes of fibrosis become apparent on CT. By combining sophisticated image analysis with CT scans obtained at full inspiration and full expiration, it may be possible to detect earlier changes of IPF than currently possible by looking at macro structural features alone. With the recent development of new therapeutics for IPF, early detection of the disease and improved monitoring of treatment efficacy will become important. Using CT to assess regional lung compliance has the potential to become an easily translated clinical tool.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Inspiration and expiration chest CT
Measure lung function
Time frame: Study visit 1 of a single visit study
A computer algorithm will compare the inspiration and expiration CT scans to determine regional lung motion.
Time frame: Study visit 1 of a single visit study
Lobar strain (S): the volumetric strain of each lobe i [i = Right Upper (RU), Right Lower (RL), Left Lower (LL), and Left Upper (LU)] as the difference in lobe volume between the expanded and contracted states, normalized by the lobe volume in the expanded state
University of Missouri-Columbia
Other
Assessment of Lung Movement With CT in Healthy Subjects and Patients With ILD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07712952
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Seoul, South Korea
View Trial DetailsNCT04708782
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Birmingham, Alabama, United States
View Trial DetailsNCT05255991
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
View Trial DetailsNCT02036970
Acute Interstitial Pneumonitis, Bronchial Diseases
Phoenix, Arizona, United States
View Trial Details